CancerFree Biotech is focused on circulating tumor cells (CTCs) culture and building CTC-derived organoids (CDOs). With our technology, we maintain the cancer stem cell property and the tumor heterogeneity, providing high-quality, personalized patient-derived tumor models that represent epitopes of primary and distal tumor cells for customers. Our breakthrough technology allows for the analysis of over 100 different solid tumor models just via liquid biopsy. This can optimize the cancer vaccine development process and ex vivo immune cell training. Our platform-Ex Vivo Avatar (E.V.A.) Select can also be used for a variety of other cancer research applications such as anti-tumor drug testing and new drug development. With our tumor model, you can get detailed analysis and information from patient-derived tumor cells to facilitate comprehensive cancer management.